IP Library › Assignment 037600/0246
Patent Assignment
Reel/Frame 037600/0246

Assignment of Assignor's Interest

Recorded: 2016-01-27 Pages: 6
Assignor
ALEXION PHARMA HOLDING
Executed: 2016-01-26
Assignee
ALEXION PHARMACEUTICALS, INC.
ALEXION PHARMACEUTICALS, INC., 352 KNOTTER DRIVE, CHESHIRE, CONNECTICUT, 06410
Covered Properties (12)
Compositions Comprising Alkaline Phosphatase and/or Natriuretic Peptide and Methods of Use Thereof
Compositions Comprising Alkaline Phosphatase and/or Natriuretic Peptide and Methods of Use Thereof
Nucleic Acid Molecule, Method and Kit for Selecting a Nucleic Acid Having a Desired Feature
Patent: 6,830,885 →
Application: 09/641,931 →
Composition, Methods and Reagents for the Synthesis of a Soluble Form of Human Phex
Patent: 6,790,649 →
Application: 09/913,955 →
Method and Compositions for Promoting Osteogenesis
Patent: 7,399,466 →
Application: 10/362,259 →
Publication: US 2005/0069569
Bone Polypeptide-1
Patent: 7,425,531 →
Application: 10/499,762 →
Publication: US 2005/0143562
Derivatives of Succinic and Glutaric Acids and Analogs Thereof Useful as Inhibitors of Phex
Patent: 7,105,539 →
Application: 10/727,119 →
Publication: US 2004/0186301
Composition, Methods and Reagents for the Synthesis of a Soluble Form of Human Phex
Patent: 7,427,498 →
Application: 10/862,459 →
Publication: US 2004/0234518
Method of Use of Specific Natriuretic Peptide Receptor C Ligands, Transgenic Non-Human Mammals Expressing Specific Natriuretic Peptide Receptor C Antagonists and Cells Thereof
Patent: 7,470,668 →
Application: 11/210,631 →
Publication: US 2007/0049521
Derivatives of Succinic and Glutaric Acids and Analogs Thereof Useful as Inhibitors of Phex
Patent: 7,365,091 →
Application: 11/441,764 →
Publication: US 2006/0287280
Compositions Comprising Natriuretic Peptides and Methods of Use Thereof
Patent: 9,266,939 →
Application: 13/336,651 →
Publication: US 2012/0164142
Compositions Comprising Alkaline Phosphatase and/or Natriuretic Peptide and Methods of Use Thereof
Application: 13/899,359 →
Publication: US 2013/0323244
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 18, 2000
From: LANCTOT, CHRISTIAN; MOFFAT, PIERRE; SALOIS, PATRICK
To: PHENOGENE THERAPEUTIQUES INC.
Reel/Frame 011032/0476 →
Assignment of Assignor's Interest Aug 21, 2001
From: CRINE, PHILIPPE; BOILEAU, GUY
To: UNIVERSITE DE MONTREAL
Reel/Frame 012258/0956 →
Assignment of Assignor's Interest Mar 25, 2003
From: CRINE, PHILIPPE; BOILEAU, GUY
To: UNIVERSITE DE MONTREAL
Reel/Frame 013888/0469 →
Assignment of Assignor's Interest Oct 30, 2003
From: BOILEAU, GUY
To: BIOMEP INC.
Reel/Frame 014639/0645 →
Assignment of Assignor's Interest Jun 1, 2004
From: GRAVEL, DENIS; RATEMI, ELAREF S.; HATAM, MOSTAFA; BOILEAU, GUY
To: BIOMEP INC.
Reel/Frame 015398/0937 →
Assignment of Assignor's Interest Aug 9, 2004
From: LANCOT, CHRISTIAN; SALOIS, PATRICK; MOFFATT, PIERRE
To: PHENOGENE THERAPEUTIQUES
Reel/Frame 015656/0907 →
Assignment of Assignor's Interest Aug 29, 2005
From: BIOMEP INC.
To: ENOBIA PHARMA
Reel/Frame 016922/0040 →
Assignment of Assignor's Interest Nov 10, 2005
From: UNIVERSITE DE MONTREAL
To: ENOBIA PHARMA INC.
Reel/Frame 017004/0199 →
Assignment of Assignor's Interest Nov 10, 2005
From: UNIVERSITE DE MONTREAL
To: ENOBIA PHARMA INC.
Reel/Frame 017003/0258 →
Change of Name Dec 1, 2005
From: BIOMEP INC.; ENOBIA PHARMA INC.
To: ENOBIA PHARMA INC.
Reel/Frame 016838/0119 →
Corrective Assignment to Correct the Second Assignor Previously Recorded on Reel 016838 Frame 0119. Assignor(S) Hereby Confirms the Second Assignor Is to Be Removed. Dec 2, 2005
From: BIOMEP, INC.
To: ENOBIA PHARMA INC.
Reel/Frame 016845/0041 →
Assignment of Assignor's Interest Dec 7, 2005
From: LANCTOT, CHRISTIAN; MOFFATT, PIERRE; THOMAS, GETHIN
To: ENOBIA PHARMA INC.
Reel/Frame 016864/0247 →
Assignment of Assignor's Interest Jul 30, 2008
From: PHENOGENE THERAPEUTIQUES INC.
To: T2C2/BIO 2000, SOCIETE EN COMMANDITE
Reel/Frame 021314/0943 →
Change of Name Jul 30, 2008
From: BIOMEP INC.
To: ENOBIA PHARMA INC.
Reel/Frame 021315/0096 →
Assignment of Assignor's Interest Jul 30, 2008
From: T2C2/BIO 2000, SOCIETE EN COMMANDITE
To: BIOMEP INC.
Reel/Frame 021314/0954 →
Change of Name Nov 5, 2008
From: BIOMEP INC.
To: ENOBIA PHARMA INC.
Reel/Frame 021785/0521 →
Assignment of Assignor's Interest Nov 5, 2008
From: T2C2/BIO 2000, SOCIETE EN COMMANDITE
To: BIOMEP INC.
Reel/Frame 021785/0472 →
Assignment of Assignor's Interest Nov 5, 2008
From: PHENOGENE THERAPEUTIQUES INC.
To: T2C2/BIO 2000, SOCIETE EN COMMANDITE
Reel/Frame 021785/0438 →
Assignment of Assignor's Interest Jan 4, 2012
From: CRINE, PHILIPPE; JOUBERT, SIMON; PARAT, MARIE
To: ENOBIA PHARMA INC.
Reel/Frame 027477/0571 →
Assignment of Assignor's Interest Jan 24, 2012
From: CRINE, PHILIPPE; BOILEAU, GUY
To: UNIVERSITE DE MONTREAL
Reel/Frame 027586/0759 →
Assignment of Assignor's Interest Jan 24, 2012
From: CRINE, PHILIPPE; BOILEAU, GUY
To: UNIVERSITE DE MONTREAL
Reel/Frame 027586/0598 →
Assignment of Assignor's Interest Jan 24, 2012
From: BIOMEP INC.
To: ENOBIA PHARMA
Reel/Frame 027585/0680 →
Assignment of Assignor's Interest Jan 24, 2012
From: GRAVEL, DENIS; RATEMI, ELAREF S.; HATAM, MOSTAFA; BOILEAU, GUY
To: BIOMEP INC.
Reel/Frame 027585/0582 →
Assignment of Assignor's Interest Feb 23, 2012
From: ENOBIA PHARMA INC.
To: ENOBIA CANADA LIMITED PARTNERSHIP
Reel/Frame 027752/0067 →
Assignment of Assignor's Interest Jun 7, 2012
From: CRINE, PHILLIPPE
To: ENOBIA CANADA LIMITED PARTNERSHIP
Reel/Frame 028336/0720 →